Angelica Loskog

11PUBLICATIONS
35CO-AUTHORS
Molecular targetsMedical devicesCancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)Medical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Apr 29, 2026
Tumor Microenvironment Gene Engineering with LOAd703 in Patients with Solid Malignancies: LOKON002 Phase I/IIb Clinical Trial.

|Feb 16, 2026
LOAd703-induced tumor microenvironment gene engineering in combination with atezolizumab in metastatic malignant melanoma: a phase I/II trial.

O Hamid, V Ekström-Rydén, I Mehmi

|Mar 18, 2024
CD40 stimulation via CD40 ligand enhances adenovirus-mediated tumour immunogenicity including 'find-me', 'eat-me', and 'kill-me' signalling.

Sedigheh Naseri, Mariela Mejia Cordova, Jessica Wenthe

|Aug 04, 2023
Single-Cell RNA Analysis Reveals Cell-Intrinsic Functions of CAR T Cells Correlating with Response in a Phase II Study of Lymphoma Patients.

Tina Sarén, Mohanraj Ramachandran, Gustav Gammelgård

|Dec 15, 2020
Intratumoral immunostimulatory AdCD40L gene therapy in patients with advanced solid tumors.

Sandra Irenaeus, Vivan Hellström, Jessica Wenthe

|May 02, 2020
Immunostimulatory oncolytic virotherapy for multiple myeloma targeting 4-1BB and/or CD40.

Jessica Wenthe, Sedigheh Naseri, Ann-Charlotte Hellström

Pageof 2

Frequent Collaborators

5 joint publications

Jessica Wenthe

4 joint publications

Tanja Lövgren

3 joint publications

Vivan Hellström

2 joint publications

Salem Alsaqal